Drug pricing: Could Labour’s “radical” plan work?

BMJ

4 October 2019 - A necessary reform or a threat to research?

At its annual conference in Brighton last week the Labour Party announced a new plan that it claimed would reduce drug prices and ensure that NHS patients were not denied access to treatment because of cost.

The party pledged that if it were elected it would use compulsory licensing to enable access to generic versions of patented drugs where the patented versions were unavailable. In the longer term, it promised to create a publicly owned company to manufacture generic drugs.

Read BMJ article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

England , Medicine , Regulation , Pricing